Alnylam Pharmaceuticals, Inc.
ALNY
$292.03
$7.192.52%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.01B | 2.91B | 2.72B | 2.86B | 2.63B |
| Total Receivables | 883.96M | 777.57M | 964.77M | 567.11M | 418.04M |
| Inventory | 84.03M | 82.72M | 75.38M | 71.69M | 65.58M |
| Prepaid Expenses | 242.10M | 281.89M | 188.04M | 147.31M | 152.42M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 4.22B | 4.05B | 3.95B | 3.64B | 3.27B |
|
|
|||||
| Total Current Assets | 4.22B | 4.05B | 3.95B | 3.64B | 3.27B |
| Net Property, Plant & Equipment | 707.56M | 708.06M | 693.14M | 692.19M | 695.92M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 202.68M | 207.61M | 205.71M | 230.13M | 249.64M |
| Total Assets | 5.13B | 4.97B | 4.85B | 4.57B | 4.21B |
|
|
|||||
| Total Accounts Payable | 126.63M | 115.72M | 117.59M | 102.39M | 97.40M |
| Total Accrued Expenses | 946.49M | 821.34M | 1.15B | 918.97M | 704.17M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 273.15M | 265.59M | 160.45M | 143.62M | 127.80M |
| Total Finance Division Other Current Liabilities | 3.21M | 263.70M | 123.79M | 135.87M | 146.26M |
| Total Other Current Liabilities | 3.21M | 263.70M | 123.79M | 135.87M | 146.26M |
| Total Current Liabilities | 1.35B | 1.47B | 1.56B | 1.30B | 1.08B |
|
|
|||||
| Total Current Liabilities | 1.35B | 1.47B | 1.56B | 1.30B | 1.08B |
| Long-Term Debt | 2.48B | 2.48B | 2.39B | 2.37B | 2.36B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 218.03M | 225.09M | 223.42M | 224.45M | 230.06M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.61M | 7.59M | 449.43M | 418.47M | 428.31M |
| Total Liabilities | 4.05B | 4.18B | 4.62B | 4.32B | 4.10B |
|
|
|||||
| Common Stock & APIC | 7.60B | 7.51B | 7.42B | 7.69B | 7.50B |
| Retained Earnings | -6.50B | -6.70B | -7.16B | -7.41B | -7.35B |
| Treasury Stock & Other | -24.89M | -20.10M | -21.78M | -29.95M | -37.52M |
| Total Common Equity | 1.08B | 789.18M | 233.89M | 250.59M | 115.44M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.08B | 789.18M | 233.89M | 250.59M | 115.44M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.08B | 789.18M | 233.89M | 250.59M | 115.44M |
|
|
|||||